1 not yet recruiting. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Not yet recruiting 1 |
Follow JNJ-99245354: new trials by email Literature Review of JNJ-99245354 trials Research Report on JNJ-99245354
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of JNJ-99245354 (ITI-1284) as an Adjunctive Treatment in Participants With Generalized Anxiety Disorder (GAD) Who Have an Inadequate Response to GAD Treatment JNJ-99245354, Placebo - Generalized Anxiety Disorder | Phase 3 | Not yet recruiting | Intra-Cellular Therapies, Inc. | 705 | 2026-09-30 | 2026-10-02 |
Generalized Anxiety Disorder (1)
Intra-Cellular Therapies, Inc. (1)